JASMINE MILLER: Open Payments
NPI 1265203327 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 36 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $41 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $159 |
| HARMONY BIOSCIENCES LLC | 2 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
| Ardelyx, Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Medtronic, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $36 |
| Endo USA, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: WAKIX, UBRELVY, INGREZZA, ENTYVIO, IBSRELA, AUSTEDO XR, NURTEC ODT, QULIPTA.
Industry payments across IN — which companies pay providers there.
